New Guidelines Advocate for Earlier Initiation of HIV PrEP in Adolescents

August 08, 2025 – Updated guidelines released this week recommend offering HIV pre-exposure prophylaxis (PrEP) to all adolescents aged 13 to 17 who are sexually active and at risk for HIV acquisition, irrespective of their gender. This represents a critically important shift from previous recommendations, which frequently enough prioritized PrEP for high-risk individuals and generally deferred initiation until age 18.

The updated guidance, jointly issued by the CDC and several leading professional organizations, reflects growing evidence demonstrating the effectiveness and safety of PrEP in adolescents, as well as the increasing incidence of HIV among this population.

“We’re seeing a concerning trend of rising HIV rates in young people, especially among those who are sexually active,” said Dr. Amelia Thompson, lead author of the guidelines and an infectious disease specialist at the University of California, San Francisco. “These guidelines are a call to action to proactively protect this vulnerable population.”

Key Changes and Rationale

The most notable change is the broadened proposal for PrEP eligibility. Previously, adolescent PrEP initiation often required demonstrating high-risk sexual behaviors, such as inconsistent condom use or multiple partners. The new guidelines emphasize a more universal approach, advocating for PrEP consideration for all sexually active adolescents at risk.

Several factors contributed to this shift:

Efficacy in Adolescents: Clinical trials have consistently shown PrEP to be highly effective in preventing HIV acquisition among adolescents, with adherence rates comparable to those seen in adults. Safety Profile: PrEP has been demonstrated to be safe for adolescents, with minimal side effects. Routine monitoring for renal function and sexually transmitted infections remains crucial.
Addressing Disparities: Young people of color, particularly Black and Hispanic/Latino adolescents, are disproportionately affected by HIV. Broadening PrEP access can help address these health inequities.
Developmental Considerations: Adolescents may face unique barriers to consistent condom use, such as power imbalances in relationships or lack of access to sexual health education. PrEP offers an additional layer of protection.

Implementation Challenges and considerations

While the updated guidelines are a positive step, several challenges remain in ensuring widespread PrEP implementation for adolescents.

Parental Consent: Navigating parental consent laws varies by state. Providers must be aware of local regulations and work to engage both adolescents and their parents in informed decision-making. Some states allow adolescents to consent to PrEP independently, recognizing their maturity and the urgency of HIV prevention.
Provider Education: Many healthcare providers may not be fully familiar with adolescent PrEP guidelines or agreeable discussing sexual health with young people. Increased training and education are essential.
Access to Care: Ensuring access to PrEP services, including HIV testing, prep prescriptions, and follow-up care, can be challenging, particularly in rural or underserved areas.
Adherence Support: Adherence to daily PrEP is crucial for its effectiveness. Providers should offer ongoing support and counseling to help adolescents stay on track.

Looking Ahead

Experts anticipate that these new guidelines will significantly impact HIV prevention efforts among adolescents.

“This is a game-changer,” said Dr. David Miller, an HIV prevention advocate. “By proactively offering prep to all at-risk adolescents, we can dramatically reduce the number of new HIV infections in this population and move closer to ending the HIV epidemic.”

the guidelines also call for increased research to further refine PrEP strategies for adolescents, including exploring long-acting injectable PrEP formulations and developing more effective adherence interventions. Continued efforts to address the social and structural factors that contribute to HIV risk among young people are also essential.## Bill Aims to Bolster ID Workforce Through Loan Repayment Programs

In a press release supporting the bill, the Infectious Diseases Society of America said refunding the programs “will create new loan repayment programs for public health and infectious diseases, HIV and emergency preparedness health care professionals who work in health shortage areas – providing a much-needed financial incentive to encourage individuals to pursue careers in public health and ID.”

“Unluckily,many patients substantially struggle to access ID physician care as nearly 80% of U.S. counties do not have a single ID physician. With only half of ID training programs filling their positions in the past 2 years,we continue to face a serious recruitment shortfall,” IDSA president Mother Tan, MD, Fidsa, FPIDS, CA, said in the press release.

We spoke with AmaJezek, senior vice president of public policy and government relations at IDSA, about the bill and what else can be done to bolster the ID workforce.

Healio: What is the bill?

Jezek: This is a bill that would reauthorize two programs that currently exist but have not yet been funded. The first program is the Public Health Workforce Loan Repayment Program and than the second is the Bio Preparedness Workforce Pilot Program.

Healio: what would these programs do?

Jezek: Both of these programs are intended to incentivize people to go into really critical parts of the workforce and to work in the areas where they are most needed. So, the first one would provide up to 3 years of student loan repayment for individuals who work in a state or local health department – and this is really aimed at trying to strengthen that state and local public health capacity for our routine needs such as respiratory virus season and various ongoing public health needs, as well as be prepared and able to respond to future outbreaks, emerging threats and pandemics.

The second piece is really focused on making sure that there are good partners within health care facilities, because we know we need people in public health departments and people in health care facilities to address both ongoing and emerging ID needs. The Bio-Preparedness Workforce Pilot Program would incentivize health care professionals to specialize in ID or emergency preparedness – and when I say health care professionals, that can be physicians, nurse practitioners, physicians assistants, pharmacists, clinical lab personnel and infection preventionistsso really looking at that whole ID team. This would incentivize health care professionals to work in ID or emergency preparedness and to work in a health professional shortage area,a medically underserved community or a federal facility such as a Veterans Affairs (VA) hospital,VA clinic,community health center or Ryan White clinic by offering up to 3 years of student loan repayment.

We certainly know that we have recruitment challenges in the field of ID that are much more pronounced than what

New CMS Code Boosts Reimbursement for Infectious Disease Physicians

The Centers for Medicare & Medicaid Services (CMS) recently implemented a new inpatient add-on code for infectious disease (ID) physicians. This code allows clinicians to seek additional reimbursement when managing particularly complex patients and performing work not covered by standard evaluation and management codes. This change aims to improve the financial viability of the infectious disease specialty.

The Infectious Diseases Society of America (IDSA) is actively working to ensure current ID physicians are aware of and utilizing this new code appropriately.The hope is that increased reimbursement will positively influence the perceptions of compensation within the field, attracting more residents and medical students to specialize in infectious disease.

Beyond financial incentives, IDSA provides resources for members to negotiate optimal compensation packages. Recognizing that compensation isn’t the sole motivator, IDSA also emphasizes the dynamic and rewarding nature of the infectious disease specialty to medical students and residents.